Differential Cytotoxicity of PVP-Copper Nanoparticles in Breast Cancer Cell Lines: Insights from Basal Transcriptomic Profiles
Anelise Goncalves SilvaiD, Izaque Junior Oliveira SilvaiD, Pedro Paranhos TanakaiD, Matheus Zaia MonteiroiD, Sergio Servilha Oliveira Filho, Jefferson Felipe Moreira de Oliveira, Valéria S. MarangoniiD, Sandra Martha Gomes DiasiD, Cyro von Zuben de Valega NegrãoiD
Abstract
Breast cancer is a heterogeneous disease comprising molecular subtypes with distinct therapeutic vulnerabilities. Among emerging therapeutic strategies, copper-based nanoparticles have shown anticancer activity. However, whether these responses differ across breast cancer subtypes and which molecular programs underlie copper sensitivity remain poorly understood. We investigated subtype-specific responses to Polyvinylpyrrolidone-assisted copper nanoparticles (CuNP-PVP) in breast cancer cell lines and the molecular programs underlying copper adaptation. CuNP-PVP were synthesized and evaluated in luminal (MCF-7), HER2-positive (SKBR3), and triple-negative (MDA-MB-231) breast cancer cell lines, with transcriptomic analyses integrated with CCLE and TCGA-BRCA datasets. UV-Vis spectroscopy revealed a plasmon resonance band at 591 nm, while TEM showed spherical nanoparticles with an average diameter of 76.1 +/- 21.0 nm. DLS indicated a larger hydrodynamic diameter, consistent with PVP coating; {zeta}-potential measurements showed a surface charge of -13 mV, and XPS confirmed mixed reduced and Cu(I)/Cu(II) oxidation states. Exposure to 100 g/mL CuNP-PVP induced subtype-dependent effects on cell viability, with MCF-7 showing greater sensitivity, whereas MDA-MB-231 and SKBR3 were less affected. Baseline transcriptomic analyses revealed enrichment of oxidative stress, metabolic adaptation, and lysosomal programs in less sensitive cells, whereas MCF-7 showed higher expression of lipoylation-related genes. These features supported the development of a Potential Biological Copper-Response Index (PBCRI), which captured subtype-associated transcriptional patterns across independent cell lines and patient tumors, with luminal models showing lower scores and basal/TNBC models showing higher scores. Together, these findings identify candidate transcriptional programs associated with subtype-specific responses to CuNP and provide a framework for investigating potential molecular determinants of copper sensitivity.
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 0
- Organism
- Assay
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Copper oxide nanoparticles function as antineoplastic agents in uterine cancer cell lines
Jordan D Berezowitz, Claire E. Rowlands, … Brittany E. Givens·bioRxiv·Jun 10, 2026
- Methyl-substituted 1,10-phenanthroline derivatives in copper(II) complexes enhance antitumor activity and inhibit NHE1 in MDA-MB-231 breast cancer cells
Katherine Seneth Muñoz Garzón, Verónica Celeste De Giusti, … Ana Laura Di Virgilio·bioRxiv·Sep 9, 2026
- High Throughput Transcriptomics to Understand Chemical Drivers of Aggressive Breast Cancer Subtypes
K. E. Sala-Hamrick, A. Tapaswi, … J. A. Colacino·bioRxiv·Nov 16, 2022
- Physicochemical changes in plasma membrane mirror nanoparticle-mediated cytotoxicity
V. Sood, D. S. Katti·bioRxiv·Dec 29, 2019
- Study the Effect of Green Method Synthesis of Copper Nanoparticles with Ionization Radiation on Lactate Dehydrogenase (LDH)
Baydaa Taher Sih·bioRxiv·Oct 31, 2024
- Role of the NHE1 exchanger in the antitumor effects of copper(II) complexes and phenanthroline derivatives
Katherine Seneth Muñoz Garzón, V. Martínez, … A. L. Di Virgilio·JBIC Journal of Biological Inorganic ChemistryPeer-reviewed·Mar 21, 2026